Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2016

Oct 5, 2016

34129_dirs_2016-10-05_e44d0097-adf4-4014-8923-b9b8a19fd8ac.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2016-10-03

Reporting Person: Cilinski Lynn (VP, Controller and Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-10-03 Common Stock M 6231 $0.94 Acquired 8154 Direct
2016-10-03 Common Stock S 6231 $29.28 Disposed 1923 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-10-03 Employee Stock Option (right to buy) $0.94 M 2237 Disposed 2019-01-10 Common Stock (2237) Direct
2016-10-03 Employee Stock Option (right to buy) $0.94 M 3994 Disposed 2020-01-09 Common Stock (3994) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: This transaction was executed in multiple trades at prices ranging from $28.755 to $29.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.